Login / Signup

Targeting Fn14 as a therapeutic target for cachexia reprograms the glycolytic pathway in tumour and brain in mice.

Ingrid Julienne Georgette BurvenichLaura Danielle OsellameAngela RigopoulosNhi HuynhZhipeng CaoNicholas Johannes HoogenraadAndrew Mark Scott
Published in: European journal of nuclear medicine and molecular imaging (2024)
Our results demonstrate that Fn14 receptor activation is linked to glucose metabolism of cachexia-inducing tumours.
Keyphrases
  • resting state
  • white matter
  • high fat diet induced
  • cancer therapy
  • functional connectivity
  • cerebral ischemia
  • type diabetes
  • multiple sclerosis
  • drug delivery
  • brain injury